​

Funding Round

Series E - Moderna

Series E - Moderna

Investment Firm

Overview

Moderna Therapeutics is a biotechnology company that specializes in vaccines and drug development.

Announced Date

Jan 05, 2015

Closed on Date

Jan 05, 2015

Funding Type

Series E

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

6

Investor Name
Participant InvestorRA Capital Management
Participant InvestorAlexion Pharmaceuticals
Participant InvestorInvus
Participant InvestorAstraZeneca
Participant InvestorWellington Management

Round Details and Background

Moderna raised $450000000 on 2015-01-05 in Series E

Moderna Therapeutics is a biotechnology company that specializes in vaccines and drug development.

Company Funding History

15

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 14, 2014
Corporate Round - Moderna
1-25.0M
Nov 20, 2013
Venture Round - Moderna
1-110.0M
Oct 02, 2013
Grant - Moderna
1-24.6M
Dec 06, 2012
Venture Round - Moderna
1-40.0M

Recent Activity

There is no recent news or activity for this profile.